{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:40:32Z","timestamp":1777977632020,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024037","name":"Cochin institute","doi-asserted-by":"crossref","award":["ANR Chrono ANR-19-CE35-0009"],"award-info":[{"award-number":["ANR Chrono ANR-19-CE35-0009"]}],"id":[{"id":"10.13039\/501100024037","id-type":"DOI","asserted-by":"crossref"}]},{"name":"International Centers of Excellence for Malaria Research (ICEMR), West Africa","award":["U19AI089696"],"award-info":[{"award-number":["U19AI089696"]}]},{"name":"Institut Pasteur, Paris, the French Government (Agence Nationale de la Recherche), Laboratoire d\u2019Excellence (LabEx) \u201cFrench Parasitology Alliance for Health Care\u201d","award":["ANR-11-15 LABX-0024-PARAFRAP"],"award-info":[{"award-number":["ANR-11-15 LABX-0024-PARAFRAP"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malaria control is highly dependent on the effectiveness of artemisinin-based combination therapy (ACT), the current frontline malaria curative treatment. Unfortunately, the emergence and spread of parasites resistant to artemisinin (ART) derivatives in Southeast Asia and South America, and more recently in Rwanda and Uganda (East Africa), compromise their long-term use in sub-Saharan Africa, where most malaria deaths occur.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Here, ex vivo susceptibility to dihydroartemisinin (DHA) was evaluated from 38\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      isolates collected in 2017 in Thi\u00e8s (Senegal) expressed in the Ring-stage Survival Assay (RSA). Both major and minor variants were explored in the three conserved-encoding domains of the\n                      <jats:italic>pfkelch13<\/jats:italic>\n                      gene, the main determinant of ART resistance using a targeted-amplicon deep sequencing (TADS) approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All samples tested in the ex vivo RSA were found to be susceptible to DHA (parasite survival rate\u2009&lt;\u20091%). The non-synonymous mutations K189T and K248R\u00a0in\n                      <jats:italic>pfkelch13<\/jats:italic>\n                      were observed each in one isolate, as major (99%) or minor (5%) variants, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results suggest that ART is still fully effective in the Thi\u00e8s region of Senegal in 2017. Investigations combining ex vivo RSA and TADS are a useful approach for monitoring ART resistance in Africa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-023-04588-1","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T11:02:19Z","timestamp":1685098939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017"],"prefix":"10.1186","volume":"22","author":[{"given":"Mamadou Samb","family":"Yade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baba","family":"Di\u00e8ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Copp\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminata","family":"Mbaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamadou Alpha","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadim","family":"Diongue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atikatou","family":"Mama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awa","family":"Fall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alphonse Birane","family":"Thiaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahima Mbaye","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolla","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Gaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdoulaye","family":"Tine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younouss","family":"Di\u00e9dhiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amadou Mactar","family":"Mbaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Doderer-Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamane Nassirou","family":"Garba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Kristine","family":"Bei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daouda","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"4588_CR1","unstructured":"WHO. Guidelines for malaria. WHO\/UCN\/GMP\/2022.01 Rev. 2. Geneva. World Health Organization; 2022."},{"key":"4588_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12936-020-03264-y","volume":"19","author":"R Nzoumbou-Boko","year":"2020","unstructured":"Nzoumbou-Boko R, Pant\u00e9-Wockama CBG, Ngoagoni C, Petiot N, Legrand E, Vickos U, et al. Molecular assessment of kelch13 non-synonymous mutations in Plasmodium falciparum isolates from central African Republic (2017\u20132019). Malar J. 2020;19:191.","journal-title":"Malar J"},{"key":"4588_CR3","volume-title":"Plan strat\u00e9gique national de lutte contre le paludisme 2016\u20132020","author":"Programme National de Lutte contre le Paludisme (PNLP)","year":"2015","unstructured":"Programme National de Lutte contre le Paludisme (PNLP). Plan strat\u00e9gique national de lutte contre le paludisme 2016\u20132020. Senegal: Dakar; 2015."},{"key":"4588_CR4","unstructured":"WHO. Tackling emerging antimalarial drug resistance in Africa. Geneva, World Health Organization, https:\/\/www.who.int\/news\/item\/18-11-2022-tackling-emerging-antimalarial-drug-resistance-in-africa."},{"key":"4588_CR5","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120\u20138.","journal-title":"Lancet Infect Dis"},{"key":"4588_CR6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"4588_CR7","volume-title":"World malaria report 2021","author":"WHO","year":"2021","unstructured":"WHO. World malaria report 2021. Geneva: World Health Organization; 2021."},{"key":"4588_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/cid\/ciac162","volume":"75","author":"R Copp\u00e9e","year":"2022","unstructured":"Copp\u00e9e R, Bailly J, Sarrasin V, Vianou B, Zinsou BE, Mazars E, et al. Circulation of an artemisinin-resistant malaria lineage in a traveler returning from East Africa to France. Clin Infect Dis. 2022;75:1242\u20134.","journal-title":"Clin Infect Dis"},{"key":"4588_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"4588_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis. 2013;13:1043\u20139.","journal-title":"Lancet Infect Dis"},{"key":"4588_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"4588_CR12","doi-asserted-by":"publisher","first-page":"10675","DOI":"10.1038\/s41598-019-47034-6","volume":"9","author":"R Copp\u00e9e","year":"2019","unstructured":"Copp\u00e9e R, Jeffares DC, Miteva MA, Sabbagh A, Clain J. Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13. Sci Rep. 2019;9:10675.","journal-title":"Sci Rep"},{"key":"4588_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","volume":"18","author":"R Amato","year":"2018","unstructured":"Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337\u201345.","journal-title":"Lancet Infect Dis"},{"key":"4588_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/AAC.04144-14","volume":"59","author":"J Feng","year":"2014","unstructured":"Feng J, Li J, Yan H, Feng X, Xia Z. Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China. Antimicrob Agents Chemother. 2014;59:326\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"4588_CR15","doi-asserted-by":"publisher","first-page":"e00802","DOI":"10.1128\/AAC.00802-19","volume":"63","author":"SA Matrevi","year":"2019","unstructured":"Matrevi SA, Opoku-Agyeman P, Quashie NB, Bruku S, Abuaku B, Koram KA, et al. Plasmodium falciparum kelch propeller polymorphisms in clinical isolates from Ghana from 2007 to 2016. Antimicrob Agents Chemother. 2019;63:e00802\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"4588_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12879-020-05266-2","volume":"20","author":"E Aninagyei","year":"2020","unstructured":"Aninagyei E, Duedu KO, Rufai T, Tetteh CD, Chandi MG, Ampomah P, et al. Characterization of putative drug resistant biomarkers in Plasmodium falciparum isolated from ghanaian blood donors. BMC Infect Dis. 2020;20:533.","journal-title":"BMC Infect Dis"},{"key":"4588_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana JLM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","journal-title":"Nat Med"},{"key":"4588_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3201\/eid2701.203527","volume":"27","author":"C Bergmann","year":"2021","unstructured":"Bergmann C, van Loon W, Habarugira F, Tacoli C, J\u00e4ger JC, Savelsberg D, et al. Increase in Kelch 13 polymorphisms in Plasmodium falciparum, Southern Rwanda. Emerg Infect Dis. 2021;27:294\u20136.","journal-title":"Emerg Infect Dis"},{"key":"4588_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","volume":"225","author":"J Straimer","year":"2022","unstructured":"Straimer J, Gandhi P, Renner KC, Schmitt EK. High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine. J Infect Dis. 2022;225:1411\u20134.","journal-title":"J Infect Dis"},{"key":"4588_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","volume":"223","author":"V Asua","year":"2021","unstructured":"Asua V, Conrad MD, Aydemir O, Duvalsaint M, Legac J, Duarte E, et al. Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda. J Infect Dis. 2021;223:985\u201394.","journal-title":"J Infect Dis"},{"key":"4588_CR21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/1475-2875-13-472","volume":"13","author":"M Torrentino-Madamet","year":"2014","unstructured":"Torrentino-Madamet M, Fall B, Benoit N, Camara C, Amalvict R, Fall M, et al. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012\u20132013. Malar J. 2014;13:472.","journal-title":"Malar J"},{"key":"4588_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1128\/AAC.01346-15","volume":"60","author":"A Boussaroque","year":"2016","unstructured":"Boussaroque A, Fall B, Madamet M, Camara C, Benoit N, Fall M, et al. Emergence of mutations in the K13 propeller gene of Plasmodium falciparum isolates from Dakar, Senegal, in 2013\u20132014. Antimicrob Agents Chemother. 2016;60:624\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"4588_CR23","doi-asserted-by":"publisher","first-page":"8907","DOI":"10.1038\/s41598-020-65553-5","volume":"10","author":"MA Diallo","year":"2020","unstructured":"Diallo MA, Yade MS, Ndiaye YD, Diallo I, Diongue K, Sy SA, et al. Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and pfcoronin molecular markers in treatment failure in Senegal. Sci Rep. 2020;10:8907.","journal-title":"Sci Rep"},{"key":"4588_CR24","doi-asserted-by":"publisher","first-page":"e0249357","DOI":"10.1371\/journal.pone.0249357","volume":"16","author":"A Ahouidi","year":"2021","unstructured":"Ahouidi A, Oliveira R, Lobo L, Diedhiou C, Mboup S, Nogueira F. Prevalence of pfk13 and pfmdr1 polymorphisms in Bounkiling, Southern Senegal. PLoS ONE. 2021;16:e0249357.","journal-title":"PLoS ONE"},{"key":"4588_CR25","doi-asserted-by":"publisher","first-page":"e02116","DOI":"10.1128\/AAC.02116-16","volume":"61","author":"E Talundzic","year":"2017","unstructured":"Talundzic E, Ndiaye YD, Deme AB, Olsen C, Patel DS, Biliya S, et al. Molecular epidemiology of Plasmodium falciparum kelch13 mutations in Senegal determined by using targeted amplicon deep sequencing. Antimicrob Agents Chemother. 2017;61:e02116\u201316.","journal-title":"Antimicrob Agents Chemother"},{"key":"4588_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12936-020-03193-w","volume":"19","author":"A Gaye","year":"2020","unstructured":"Gaye A, Sy M, Ndiaye T, Siddle KJ, Park DJ, Deme AB, et al. Amplicon deep sequencing of kelch13 in Plasmodium falciparum isolates from Senegal. Malar J. 2020;19:134.","journal-title":"Malar J"},{"key":"4588_CR27","unstructured":"WHO. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). https:\/\/www.who.int\/publications-detail-redirect\/9789240012813."},{"key":"4588_CR28","doi-asserted-by":"publisher","first-page":"e0132021","DOI":"10.1128\/AAC.01320-21","volume":"66","author":"L Paloque","year":"2022","unstructured":"Paloque L, Copp\u00e9e R, Stokes BH, Gn\u00e4dig NF, Niar\u00e9 K, Augereau JM, et al. Mutation in the Plasmodium falciparum BTB\/POZ domain of K13 protein confers artemisinin resistance. Antimicrob Agents Chemother. 2022;66:e0132021.","journal-title":"Antimicrob Agents Chemother"},{"key":"4588_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13073-017-0398-0","volume":"9","author":"W Wong","year":"2017","unstructured":"Wong W, Griggs AD, Daniels RF, Schaffner SF, Ndiaye D, Bei AK, et al. Genetic relatedness analysis reveals the cotransmission of genetically related Plasmodium falciparum parasites in Thi\u00e8s, Senegal. Genome Med. 2017;9:5.","journal-title":"Genome Med"},{"key":"4588_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijpddr.2013.07.001","volume":"3","author":"D Ndiaye","year":"2013","unstructured":"Ndiaye D, Dieye B, Ndiaye YD, Van Tyne D, Daniels R, Bei AK, et al. Polymorphism in dhfr\/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal. Int J Parasitol Drugs Drug Resist. 2013;3:135\u201342.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4588_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0035-9203(00)90300-6","volume":"94","author":"WHO","year":"2000","unstructured":"WHO. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94:1\u201390.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4588_CR32","unstructured":"Witkowski B, Menard D, Amaratunga C, Fairhurst R. Ring-stage survival assays (RSA) to evaluate the in-vitro and ex-vivo susceptibility of Plasmodium falciparum to artemisinins. Inst Pasteur Cambodge\u2013National Inst Health Proced RSAv1; 2013."},{"key":"4588_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3201\/eid2404.170141","volume":"24","author":"M Ikeda","year":"2018","unstructured":"Ikeda M, Kaneko M, Tachibana SI, Balikagala B, Sakurai-Yatsushiro M, Yatsushiro S, et al. Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016. Emerg Infect Dis. 2018;24:718\u201326.","journal-title":"Emerg Infect Dis"},{"key":"4588_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12936-016-1622-x","volume":"15","author":"S Menard","year":"2016","unstructured":"Menard S, Tchoufack JN, Maffo CN, Nsango SE, Iriart X, Abate L, et al. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates. Malar J. 2016;15:572.","journal-title":"Malar J"},{"key":"4588_CR35","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1128\/AAC.00921-15","volume":"59","author":"RA Cooper","year":"2015","unstructured":"Cooper RA, Conrad MD, Watson QD, Huezo SJ, Ninsiima H, Tumwebaze P, et al. Lack of artemisinin resistance in Plasmodium falciparum in Uganda based on parasitological and molecular assays. Antimicrob Agents Chemother. 2015;59:5061\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"4588_CR36","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(20)30493-X","volume":"21","author":"NK Kayiba","year":"2021","unstructured":"Kayiba NK, Yobi DM, Tshibangu-Kabamba E, Tuan VP, Yamaoka Y, Devleesschauwer B, et al. Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review. Lancet Infect Dis. 2021;21:e82\u201392.","journal-title":"Lancet Infect Dis"},{"key":"4588_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12936-021-03807-x","volume":"20","author":"M Riloha Rivas","year":"2021","unstructured":"Riloha Rivas M, Warsame M, Mb\u00e1 Andeme R, Nsue Esidang S, Ncogo PR, Phiri WP, et al. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea. Malar J. 2021;20:275.","journal-title":"Malar J"},{"key":"4588_CR38","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1056\/NEJMc1713777","volume":"379","author":"S Das","year":"2018","unstructured":"Das S, Saha B, Hati AK, Roy S. Evidence of artemisinin-resistant Plasmodium falciparum malaria in eastern India. N Engl J Med. 2018;379:1962\u20134.","journal-title":"N Engl J Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04588-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-023-04588-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04588-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T11:06:48Z","timestamp":1685099208000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-023-04588-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4588"],"URL":"https:\/\/doi.org\/10.1186\/s12936-023-04588-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2538775\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the Ethics Committee of the Ministry of Health in Dakar, Senegal 00000169\/MSAS\/DPRS\/CNERS (December 2, 2016). Study participants, their parents, or guardians were informed about their rights, purpose, procedure, and benefit of the study and side effects of the procedure and written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participants in this study consented for its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}